Sucampo Pharmaceuticals, Inc. Stock

Stocks

17-12-26	Wall Street slips on tech sector weakness	RE
17-12-26	Mallinckrodt : to buy Sucampo for about $840 million	RE
16-11-09	Boeing : U.S. companies react cautiously to Trump victory	RE

18-01-03	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-12-29	SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc	BU
17-12-28	CORRECTING and REPLACING Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-12-27	SUCAMPO PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
17-11-27	Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference	GL

17-12-26	Apple : POINT Marchés-Wall Street finit peu changée, freinée par Apple
17-12-26	Apple : Les valeurs à suivre à Wall Street
17-12-08	Alexion Pharmaceuticals : Les valeurs à suivre à Wall Street
17-12-07	Sucampo Pharmaceuticals : La biotech américaine Sucampo envisage de se vendre
17-04-19	Sucampo Pharmaceuticals : Veröffentlichung einer neuen Studie zu VTS-270 für die Behandlung von Morbus Niemann-Pick Typ C1 im Online-Fachjournal PLOS ONE Advances Science

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUCAMPO PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
WUXI APPTEC CO., LTD.	+1.76%	+3.62%	+49.92%	+101.12%	69.69B
ARGENX SE	+2.29%	+0.32%	+37.65%	+77.03%	61.24B
INSMED INCORPORATED	+1.14%	-3.74%	-14.35%	+365.92%	26.77B
WUXI BIOLOGICS (CAYMAN) INC.	+0.32%	+2.58%	+29.26%	+14.12%	26.12B
BIONTECH SE	+2.95%	+0.54%	-0.60%	-12.74%	24.07B
GENMAB A/S	+1.49%	+5.15%	+26.46%	-15.89%	20.39B
PHARMAESSENTIA CORPORATION	-0.83%	-11.15%	+169.70%	+295.44%	15.72B
EXELIXIS, INC.	+3.01%	+0.27%	+49.44%	+168.18%	14.07B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.17%	-4.07%	-9.71%	+484.05%	14.03B
Average	+1.23%	-1.18%	+37.53%	+164.14%	30.23B
Weighted average by Cap.	+1.60%	+0.20%	+36.44%	+129.00%